305 related articles for article (PubMed ID: 21631560)
21. A critical appraisal of the prevalence and metabolic significance of brown adipose tissue in adult humans.
Lee P; Greenfield JR; Ho KK; Fulham MJ
Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E601-6. PubMed ID: 20606075
[TBL] [Abstract][Full Text] [Related]
22. Age-related decrease in cold-activated brown adipose tissue and accumulation of body fat in healthy humans.
Yoneshiro T; Aita S; Matsushita M; Okamatsu-Ogura Y; Kameya T; Kawai Y; Miyagawa M; Tsujisaki M; Saito M
Obesity (Silver Spring); 2011 Sep; 19(9):1755-60. PubMed ID: 21566561
[TBL] [Abstract][Full Text] [Related]
23. Adrenergic pathway activation enhances brown adipose tissue metabolism: a [¹⁸F]FDG PET/CT study in mice.
Mirbolooki MR; Upadhyay SK; Constantinescu CC; Pan ML; Mukherjee J
Nucl Med Biol; 2014 Jan; 41(1):10-6. PubMed ID: 24090673
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of hepatic metabolic activity in non-alcoholic fatty livers on 18FDG PET/CT.
Dostbil Z; Varoğlu E; Serdengeçti M; Kaya B; Onder H; Sari O
Rev Esp Med Nucl Imagen Mol; 2013; 32(3):156-61. PubMed ID: 23177332
[TBL] [Abstract][Full Text] [Related]
25. Supraclavicular Brown Adipose Tissue 18F-FDG Uptake and Cardiovascular Disease.
Takx RA; Ishai A; Truong QA; MacNabb MH; Scherrer-Crosbie M; Tawakol A
J Nucl Med; 2016 Aug; 57(8):1221-5. PubMed ID: 26795284
[TBL] [Abstract][Full Text] [Related]
26. Brown fat depots in adult humans remain static in their locations on PET/CT despite changes in seasonality.
Jones TA; Reddy NL; Wayte SC; Adesanya O; Dimitriadis GK; Hutchinson CE; Barber TM
Physiol Rep; 2017 Jun; 5(11):. PubMed ID: 28588036
[TBL] [Abstract][Full Text] [Related]
27. Extensive hypermetabolic pattern of brown adipose tissue activation on 18F-FDG PET/CT in a patient diagnosed of catecholamine-secreting para-vesical paraganglioma.
Banzo J; Ubieto MA; Berisa MF; Andrés A; Mateo ML; Tardín L; Parra A; Razola P; Prats E
Rev Esp Med Nucl Imagen Mol; 2013; 32(6):397-9. PubMed ID: 23867638
[TBL] [Abstract][Full Text] [Related]
28. The relationship between brown adipose tissue activity and neoplastic status: an (18)F-FDG PET/CT study in the tropics.
Huang YC; Chen TB; Hsu CC; Li SH; Wang PW; Lee BF; Kuo CY; Chiu NT
Lipids Health Dis; 2011 Dec; 10():238. PubMed ID: 22182284
[TBL] [Abstract][Full Text] [Related]
29. Interobserver and intraobserver variability for the assessment of brown adipose tissue activity on 18F-FDG PET-CT.
Bahler L; Holleman F; Booij J; Hoekstra JB; Verberne HJ
Nucl Med Commun; 2016 Apr; 37(4):363-71. PubMed ID: 26599066
[TBL] [Abstract][Full Text] [Related]
30. Differences in Sympathetic Nervous Stimulation of Brown Adipose Tissue Between the Young and Old, and the Lean and Obese.
Bahler L; Verberne HJ; Admiraal WM; Stok WJ; Soeters MR; Hoekstra JB; Holleman F
J Nucl Med; 2016 Mar; 57(3):372-7. PubMed ID: 26609175
[TBL] [Abstract][Full Text] [Related]
31. Preparation methods prior to PET/CT scanning that decrease uptake of 18F-FDG by myocardium, brown adipose tissue, and skeletal muscle.
Shao D; Tian XW; Gao Q; Liang CH; Wang SX
Acta Radiol; 2017 Jan; 58(1):10-18. PubMed ID: 26936898
[TBL] [Abstract][Full Text] [Related]
32. The relationship between patients' serum glucose levels and metabolically active brown adipose tissue detected by PET/CT.
Jacene HA; Cohade CC; Zhang Z; Wahl RL
Mol Imaging Biol; 2011 Dec; 13(6):1278-83. PubMed ID: 21140233
[TBL] [Abstract][Full Text] [Related]
33. Hypermetabolic mesenteric brown adipose tissue on dual-time point FDG PET/CT in a patient with benign retroperitoneal pheochromocytoma.
Dong A; Wang Y; Lu J; Zuo C
Clin Nucl Med; 2014 Mar; 39(3):e229-32. PubMed ID: 23455523
[TBL] [Abstract][Full Text] [Related]
34. Factors influencing brown fat activation in FDG PET/CT: a retrospective analysis of 15,000+ cases.
Steinberg JD; Vogel W; Vegt E
Br J Radiol; 2017 Jul; 90(1075):20170093. PubMed ID: 28590773
[TBL] [Abstract][Full Text] [Related]
35. Association between habitual physical activity and brown adipose tissue activity in individuals undergoing PET-CT scan.
Dinas PC; Nikaki A; Jamurtas AZ; Prassopoulos V; Efthymiadou R; Koutedakis Y; Georgoulias P; Flouris AD
Clin Endocrinol (Oxf); 2015 Jan; 82(1):147-54. PubMed ID: 25262810
[TBL] [Abstract][Full Text] [Related]
36. Outdoor temperature, age, sex, body mass index, and diabetic status determine the prevalence, mass, and glucose-uptake activity of 18F-FDG-detected BAT in humans.
Ouellet V; Routhier-Labadie A; Bellemare W; Lakhal-Chaieb L; Turcotte E; Carpentier AC; Richard D
J Clin Endocrinol Metab; 2011 Jan; 96(1):192-9. PubMed ID: 20943785
[TBL] [Abstract][Full Text] [Related]
37. Genotype-Dependent Brown Adipose Tissue Activation in Patients With Pheochromocytoma and Paraganglioma.
Puar T; van Berkel A; Gotthardt M; Havekes B; Hermus AR; Lenders JW; van Marken Lichtenbelt WD; Xu Y; Brans B; Timmers HJ
J Clin Endocrinol Metab; 2016 Jan; 101(1):224-32. PubMed ID: 26574955
[TBL] [Abstract][Full Text] [Related]
38. Prevention of brown adipose tissue activation in 18F-FDG PET/CT of breast cancer patients receiving neoadjuvant systemic therapy.
Aukema TS; Vogel WV; Hoefnagel CA; Valdés Olmos RA
J Nucl Med Technol; 2010 Mar; 38(1):24-7. PubMed ID: 20159933
[TBL] [Abstract][Full Text] [Related]
39. Low-dose oral propranolol could reduce brown adipose tissue F-18 FDG uptake in patients undergoing PET scans.
Parysow O; Mollerach AM; Jager V; Racioppi S; San Roman J; Gerbaudo VH
Clin Nucl Med; 2007 May; 32(5):351-7. PubMed ID: 17452860
[TBL] [Abstract][Full Text] [Related]
40. Comparison of BMIPP-SPECT/CT to
Frankl JA; An Y; Sherwood A; Hao G; Huang FY; Thapa P; Clegg DJ; Sun X; Scherer PE; Öz OK
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
